September 2019 Vol 10, No 9

Ovarian cancers with BRCA mutations are less immunogenic than other DNA repair–deficient tumors.
Patients with ovarian cancer can respond to immunotherapy, but rationally designed synergistic combinations will be necessary to enhance upfront efficacy and to sustain durability, said Daniel J. Powell, Jr, PhD, Scientific Director of Immunotherapy, Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium.
A paradigm shift away from “one-size-fits-all” treatment in cancer has fueled the movement toward precision medicine, an approach to cancer treatment that ensures delivery of the right intervention to the right patient at the right time.
Adolescent and young adult (AYA) patients aged 15 to 39 years are significantly underrepresented in cancer clinical trials.
When patients’ sexual functioning is compromised as a result of cancer treatment, so is their quality of life. Here’s what navigators can do to incorporate sexual preservation into survivorship care.
Can you separate these common nutrition myths from facts?
Palliative care is not only meant to provide pain control and complex symptom management for patients with cancer; it also facilitates discussions regarding future directions of care for patients, giving them more control over their quality of life.
Navigating employment and finances after a cancer diagnosis can be enormously challenging for patients, particularly in the midst of treatment.
What you need to know about navigating a patient with mental health issues.
Addressing compassion fatigue in the oncology healthcare setting is an integral component of any oncology navigation program.

Results 1 - 13 of 13

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State